Data di Pubblicazione:
2012
Abstract:
Background: Helicobacter pylori L-asparaginase is a recently isolated bacterial factor able to inhibit the cell-cycle of exposed cells, but also a potential platform to develop new anti-cancer drugs, due to its remarkable selectivity for L-asparagine.
Methods: To generate new, useful variants of the enzyme, site directed mutagenesis and random mutagenesis are being used to introduce modifications of the protein. The latter method required finding a powerful selection method to isolate interesting mutants. Results: Site-directed mutants generated for L-asparaginase show different levels of activity both towards L-asparagine and L-glutamine.
Selecetion of random mutants is still ongoing. Conclusions: Dissection of L-
asparaginase activity towards different substrates can be useful to generate better
anti-cancer therapeutics.
Methods: To generate new, useful variants of the enzyme, site directed mutagenesis and random mutagenesis are being used to introduce modifications of the protein. The latter method required finding a powerful selection method to isolate interesting mutants. Results: Site-directed mutants generated for L-asparaginase show different levels of activity both towards L-asparagine and L-glutamine.
Selecetion of random mutants is still ongoing. Conclusions: Dissection of L-
asparaginase activity towards different substrates can be useful to generate better
anti-cancer therapeutics.
Tipologia CRIS:
4.1 Contributo in Atti di convegno
Keywords:
L-asparaginase; mutants; leukemia
Elenco autori:
Covini, Daniele; Pasquetto, MARIA VALENTINA; Tarasco, E.; Vecchia, Luca; Maggi, M.; Valentini, Giovanna; Chiarelli, Laurent; Scotti, Claudia
Link alla scheda completa:
Titolo del libro:
SIPMeT and AIPaCMeM Abstracts
Pubblicato in: